SV almost goes B(ust) 📉
Mar 17, 2023•45 min•Ep. 36
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week: Jessica Smith is joined by James, Belle and Albion VC's Molly Gilmartin.
[01:50] SVB fuelled high-risk, high-reward tech firms. Now health start-ups feel bereft
[10:00] Why do so many biotechs face being kicked off the Nasdaq?
[15:15] How UK healthtechs can get a head start on their US expansion
[28:05] Why investors should pay close attention to the UK’s healthtech sector in 2023
✍️ Apply to be a guest at this form
📖 Learn more about the SomX team at somx.health
🖇 Connect with Jessica on LinkedIn
🖇 Connect with James on LinkedIn
🖇 Connect with Belle on LinkedIn
🖇 Connect with Molly on LinkedIn
For the best experience, listen in Metacast app for iOS or Android